Back to Authors

Bah, Eugene S.

https://orcid.org/0000-0001-5984-1806

Mayo Clinic

Mayo Clinic

Citations 4

Ventral Thoracic Cerebrospinal Fluid Leak Repair in Spontaneous Intracranial Hypotension Complicated by Superficial Siderosis: 2-Dimensional Operative Video
Naylor, Ryan M. , Bah, Eugene S. , Michalopoulos, Giorgos D. , Cutsforth‐Gregory, Jeremy K. , Fogelson, Jeremy L. , Michalopoulos, Giorgos , Madhavan, Ajay A.

Operative Neurosurgery | October 1, 2024 | Volume: 28 | Issue: 6 | Pages: 893-894

10.1227/ons.0000000000001372 Get It

Complete encasement of the radial nerve by a giant lipoma: illustrative case
Bah, Eugene S. , Spinner, Robert J. , Barone, Damiano G, Barone, Damiano G.

Journal of Neurosurgery: Case Lessons | July 8, 2024 | Volume: 8 | Issue: 2 | Pages: No page available

10.3171/case24148 Get It

BACKGROUND Among the spectrum of adipose lesions associated with peripheral nerves, complete circumferential encasement of the nerve by the lesion is a very rare entity. The authors report the first case of a giant lipoma that completely and circumferentially encased the radial nerve. OBSERVATIONS A 57-year-old woman presented with a large left-arm mass that she had noticed over a year following significant weight loss. She had hypersensitivity and dysesthesias in the left posterior arm but no weakness or other symptoms. Magnetic resonance imaging of the left upper limb demonstrated a large lipoma completely encasing the radial nerve, originating at the level of the spiral grove proximally and extending distally to the lateral epicondyle. The lesion was completely resected at surgery with total preservation of radial nerve function. LESSONS Lipomas encasing peripheral nerves can be difficult to manage while preserving function. This case adds to the intriguing spectrum of adipose lesions associated with peripheral nerves. https://thejns.org/doi/10.3171/CASE24148
Structural insights into ribosome structure and translation regulation
Bah, Eugene S. , Koh, Cha San , Madireddy, Rohini, Svidritskiy, E. , Zhang, Ying , Korostelev, Andrei A.

The FASEB Journal | June 21, 2021 | Volume: 29 | Issue: S1 | Pages: No page available

10.1096/fasebj.29.1_supplement.711.23 Get It

Protein synthesis (translation) is accomplished by ribosomes in all living cells. Ribosomes decode genetic information encoded in messenger RNA and catalyze peptide‐bond formation. We study the mechanisms of translation translation regulation, using structural and biochemical methods. Here, we will present new structural insights into regulation of translation on the ribosome under cellular stress and/or disease.
Retargeted and Stealth-Modified Oncolytic Measles Viruses for Systemic Cancer Therapy in Measles Immune Patients
Bah, Eugene S. , Nace, Rebecca A., Peng, Kah Whye, Muñoz-Alía, Miguel Ángel , Russell, Stephen J. , Russell, Stephen J , Muñoz-Alía, Miguel Á

Molecular Cancer Therapeutics | August 26, 2020 | Volume: 19 | Issue: 10 | Pages: 2057-2067

10.1158/1535-7163.mct-20-0134 Get It

Abstract Measles viruses (MV) are rapidly inactivated by anti-measles neutralizing antibodies, which has limited their clinical performance as oncolytic agents. Here, by substituting the H and F surface glycoproteins of MV with those from the homologous canine distemper virus (CDV) and engineering the CDV H attachment protein to target EGFR or CD38, we generated a fully retargeted MV capable of resisting neutralization by measles-immune human serum. The resultant recombinant MVs encoding retargeted CDV envelope glycoproteins had similar growth kinetics as the control MV, showed the expected engineered receptor specificities for cell entry, intercellular fusion, and target cell killing, and were blind to native CDV receptors. In contrast to the control MV, recombinant MVs incorporating CDV F and H glycoproteins retained full infectivity when exposed to high concentrations of pooled measles-immune human serum. Comparing viruses bearing MV or CDV glycoproteins in the SKOV3ip.1 model, only the virus bearing an EGFR-retargeted CDV envelope glycoprotein complex was capable of limiting tumor growth and extending the survival in measles immune mice. MV, “stealthed” and retargeted using engineered CDV surface glycoproteins, may be a promising platform to advance for systemic cancer therapy in measles immune patients.